The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Epigenetic modifications in cancer
Open accessAbstract
Kanwal R, Gupta S. Epigenetic modifications in cancer. Cancer initiation and progression is controlled by both genetic and epigenetic events. The complexity of carcinogenesis cannot be accounted for by genetic alterations alone but also involves epigenetic changes. Epigenetics refers to the study of mechanisms that alter gene expression without altering the primary DNA sequence. Epigenetic mechanisms are heritable and reversible, and include changes in DNA methylation, histone modifications and small noncoding microRNAs (miRNA). Disruption of epigenetic processes can lead to altered gene function and malignant cellular transformation. Aberrant epigenetic modifications probably occur at a very early stage in neoplastic development, and they are widely described as essential players in cancer progression. Recent advances in epigenetics offer a better understanding of the underlying mechanism(s) of carcinogenesis and provide insight into the discovery of putative cancer biomarkers for early detection, disease monitoring, prognosis, and risk assessment. In this review, we summarize the current literature on epigenetic changes causing genetic alterations that are thought to contribute to cancer, and discuss the potential impact of epigenetics future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
Most mammalian mRNAs are conserved targets of microRNAs
Friedman, R. C., Farh, K. K.-H., Burge, C. B., & Bartel, D. P. (2009) · Genome Research · doi:10.1101/gr.082701.108 · Cited by 8,462
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143 · cited 1×
“Both the establishment and maintenance of DNA methylation patterns are critical for development as mice deficient in DNMT3B or DNMT1 are embryonic lethal and DNMT3A-null mice die by 4 weeks of age (9).”
BackgroundRegulation of chromatin by histone modifications
Bannister, A. J., & Kouzarides, T. (2011) · Cell Research · doi:10.1038/cr.2011.22 · Cited by 6,012
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
The Role of Chromatin during Transcription
Li, B., Carey, M., & Workman, J. L. (2007) · Cell · doi:10.1016/j.cell.2007.01.015 · Cited by 3,533
DNA methylation and human disease
Robertson, K. D. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1655 · Cited by 2,864
Epigenetic modifications and human disease
Portela, A., & Esteller, M. (2010) · Nature Biotechnology · doi:10.1038/nbt.1685 · Cited by 2,836
Linking DNA methylation and histone modification: patterns and paradigms
Cedar, H., & Bergman, Y. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2540 · Cited by 2,267 · cited 1×
“Histone modifications influence chromatin structure which plays an important role in gene regulation and carcinogenesis (16).”
BackgroundInactivation of the DNA-Repair Gene MGMT and the Clinical Response of Gliomas to Alkylating Agents
Esteller, M., Garcia-Foncillas, J., Andion, E., Goodman, S. N., Hidalgo, O. F., Vanaclocha, V., Baylin, S. B., & Herman, J. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431901 · Cited by 2,224
An operational definition of epigenetics: Figure 1.
Berger, S. L., Kouzarides, T., Shiekhattar, R., & Shilatifard, A. (2009) · Genes & Development · doi:10.1101/gad.1787609 · Cited by 1,884
Reduced accumulation of specific microRNAs in colorectal neoplasia.
Michael, M., Connor, S. M. O., Pellekaan, N. V. H., Young, G. P., & James, R. J. (2003) · PubMed · Cited by 1,775
Fabbri, M., Garzon, R., Cimmino, A., Liu, Z., Zanesi, N., Callegari, E., Liu, S., Alder, H., Costinean, S., Fernandez-Cymering, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707628104 · Cited by 1,673
Cancer epigenetics reaches mainstream oncology
Rodríguez-Paredes, M., & Esteller, M. (2011) · Nature Medicine · doi:10.1038/nm.2305 · Cited by 1,205
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
Dalgliesh, G. L., Furge, K., Greenman, C., Chen, L., Bignell, G., Butler, A., Davies, H., Edkins, S., Hardy, C., Latimer, C., et al. (2010) · Nature · doi:10.1038/nature08672 · Cited by 1,173 · cited 1×
“A recent study has described inactivating mutations in the histone methyltransferase SETD2 and in the histone demethylase UTX and JARID1C in renal carcinomas (36, 37).”
BackgroundMicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells
Xu, N., Papagiannakopoulos, T., Pan, G., Thomson, J. A., & Kosik, K. S. (2009) · Cell · doi:10.1016/j.cell.2009.02.038 · Cited by 1,124
Covalent histone modifications — miswritten, misinterpreted and mis-erased in human cancers
Chi, P., Allis, C. D., & Wang, G. G. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2876 · Cited by 1,099
Active DNA demethylation: many roads lead to Rome
Wu, S. C., & Zhang, Y. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2950 · Cited by 1,060
Bachmann, I. M., Halvorsen, O. J., Collett, K., Stefansson, I. M., Straume, O., Haukaas, S. A., Salvesen, H. B., Otte, A. P., & Akslen, L. A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.5180 · Cited by 851
Histone modification levels are predictive for gene expression
Karlić, R., Chung, H.-R., Lasserre, J., Vlahoviček, K., & Vingron, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909344107 · Cited by 792
Valinluck, V. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh739 · Cited by 756
Epigenetic gene silencing in cancer: the DNA hypermethylome
Esteller, M. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm018 · Cited by 725 · cited 2×
“This provides tumor cells with a growth advantage and increases their genetic instability and aggressiveness (22, 30).”
BackgroundOxidative stress, DNA methylation and carcinogenesis
Franco, R., Schoneveld, O., Georgakilas, A. G., & Panayiotidis, M. I. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.026 · Cited by 603
Cancer biology and NuRD: a multifaceted chromatin remodelling complex
Lai, A. Y., & Wade, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3091 · Cited by 539
DNA Methyltransferase Inhibitors and the Development of Epigenetic Cancer Therapies
Lyko, F., & Brown, R. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji311 · Cited by 510
Signals and Combinatorial Functions of Histone Modifications
Suganuma, T., & Workman, J. L. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061809-175347 · Cited by 499
Epigenetic mechanisms in mammals
Kim, J. K., Samaranayake, M., & Pradhan, S. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8432-4 · Cited by 498
DNA methylation and methyl-CpG binding proteins: developmental requirements and function
Bogdanović, O., & Veenstra, G. J. C. (2009) · Chromosoma · doi:10.1007/s00412-009-0221-9 · Cited by 479
Epigenetics in cancer: Targeting chromatin modifications
Ellis, L., Atadja, P. W., & Johnstone, R. W. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0860 · Cited by 479
Epigenetics and human disease: translating basic biology into clinical applications
Rodenhiser, D. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.050774 · Cited by 473
Let-7 and miR-200 microRNAs: Guardians against pluripotency and cancer progression
Peter, M. E. (2009) · Cell Cycle · doi:10.4161/cc.8.6.7907 · Cited by 404
Regulation of mammalian DNA methyltransferases: a route to new mechanisms
Denis, H., Ndlovu, '. N., & Fuks, F. (2011) · EMBO reports · doi:10.1038/embor.2011.110 · Cited by 390
Genome-Wide Profiling of DNA Methylation Reveals a Class of Normally Methylated CpG Island Promoters
Shen, L., Kondo, Y., Guo, Y., Zhang, J., Zhang, L., Ahmed, S., Shu, J., Chen, X., Waterland, R. A., & Issa, J.-P. J. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030181 · Cited by 389
DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer
Lopez-Serra, P., & Esteller, M. (2012) · Oncogene · doi:10.1038/onc.2011.354 · Cited by 360
Sensitive digital quantification of DNA methylation in clinical samples
Li, M., Chen, W.-D., Papadopoulos, N., Goodman, S. N., Bjerregaard, N. C., Laurberg, S., Levin, B., Juhl, H., Arber, N., Moinova, H., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1559 · Cited by 341
DNA methylomes, histone codes and miRNAs: Tying it all together
Guil, S., & Esteller, M. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.09.005 · Cited by 317
Interplay between microRNAs and the epigenetic machinery: An intricate network
Iorio, M. V., Piovan, C., & Croce, C. M. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.05.005 · Cited by 306
Cause and Consequences of Genetic and Epigenetic Alterations in Human Cancer
Sadikovic, B., Al-Romaih, K., Squire, J., & Zielenska, M. (2008) · Current Genomics · doi:10.2174/138920208785699580 · Cited by 290
Cancer DNA Methylation: Molecular Mechanisms and Clinical Implications
McCabe, M. T., Brandes, J. C., & Vertino, P. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2784 · Cited by 263
MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer
Olson, P., Lu, J., Zhang, H., Shai, A., Chun, M. G., Wang, Y., Libutti, S. K., Nakakura, E. K., Golub, T. R., & Hanahan, D. (2009) · Genes & Development · doi:10.1101/gad.1820109 · Cited by 260
Pandey, M., Shukla, S., & Gupta, S. (2010) · International Journal of Cancer · doi:10.1002/ijc.24988 · Cited by 218
Self-citationRational Combinations Using HDAC Inhibitors
Bots, M., & Johnstone, R. W. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2786 · Cited by 217
Dnmt3L is a transcriptional repressor that recruits histone deacetylase
Deplus, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf509 · Cited by 210
MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer
Suh, S. O., Chen, Y., Zaman, M. S., Hirata, H., Yamamura, S., Shahryari, V., Liu, J., Tabatabai, Z. L., Kakar, S., Deng, G., et al. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr036 · Cited by 206
DNA methylation of cancer genome
Cheung, H., Lee, T., Rennert, O. M., & Chan, W. (2009) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.20163 · Cited by 174
Histone Modifiers in Cancer: Friends or Foes?
Cohen, I., Poreba, E., Kamieniarz, K., & Schneider, R. (2011) · Genes & Cancer · doi:10.1177/1947601911417176 · Cited by 171
Epigenetic aberrations and cancer.
Ducasse, M., & Brown, M. A. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-60 · Cited by 170
Oxidative Stress and DNA Methylation in Prostate Cancer
Donkena, K. V., Young, C. Y. F., & Tindall, D. J. (2010) · Obstetrics and Gynecology International · doi:10.1155/2010/302051 · Cited by 168
Myzak, M., & Dashwood, R. (2006) · Current Drug Targets · doi:10.2174/138945006776359467 · Cited by 160
MicroRNAs: tools for cancer diagnostics
Paranjape, T., Slack, F. J., & Weidhaas, J. B. (2009) · Gut · doi:10.1136/gut.2009.179531 · Cited by 159
Chatting histone modifications in mammals
Izzo, A., & Schneider, R. (2010) · Briefings in Functional Genomics · doi:10.1093/bfgp/elq024 · Cited by 153
Involvement of oxidatively damaged DNA and repair in cancer development and aging.
Tudek, B., Winczura, A., Janik, J., Siomek, A., Foksiński, M., & Oliński, R. (2010) · PubMed · Cited by 143
Epigenetic Variation Illustrated by DNA Methylation Patterns of the Fragile-X Gene FMR1
Stöger, R. J., Kajimura, T., Brown, W. T., & Laird, C. D. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.11.1791 · Cited by 143
Bruserud, Ø., Stapnes, C., Ersvær, E., Gjertsen, B. T., & Ryningen, A. (2007) · Current Pharmaceutical Biotechnology · doi:10.2174/138920107783018417 · Cited by 141
Kanwal, R., & Gupta, S. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00066.2010 · Cited by 134
Self-citationLee, D.-H., O'Connor, T. R., & Pfeifer, G. P. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf478 · Cited by 124
Soussi, T., & Béroud, C. (2003) · Human Mutation · doi:10.1002/humu.10189 · Cited by 118
DNA methylation and cancer diagnosis: new methods and applications
Dehan, P., Kustermans, G., Guénin, S., Horion, J., Boniver, J., & Delvenne, P. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.53 · Cited by 102
Rahman, N., & Scott, R. H. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm026 · Cited by 95
MicroRNAs in clinical oncology: at the crossroads between promises and problems
Metias, S., Lianidou, E. S., & Yousef, G. M. (2009) · Journal of Clinical Pathology · doi:10.1136/jcp.2009.064717 · Cited by 89
Oxidative damage to 5-methylcytosine in DNA
Zuo, S., Boorstein, R. J., & Teebor, G. W. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.16.3239 · Cited by 87
Impact of 7,8-Dihydro-8-oxoguanine on Methylation of the CpG Site by Dnmt3a
Maltseva, D. V., Baykov, A. A., Jeltsch, A., & Gromova, E. S. (2009) · Biochemistry · doi:10.1021/bi801947f · Cited by 86
Loss of Imprinting of IGF2 as an Epigenetic Marker for the Risk of Human Cancer
Cui, H. (2007) · Disease Markers · doi:10.1155/2007/363464 · Cited by 85
Evidence for heritable predisposition to epigenetic silencing of MLH1
Chen, H., Taylor, N. P., Sotamaa, K., Mutch, D. G., Powell, M. A., Schmidt, A. P., Feng, S., Hampel, H. L., de la Chapelle, A., & Goodfellow, P. J. (2007) · International Journal of Cancer · doi:10.1002/ijc.22406 · Cited by 80
Expression of p16 induces transcriptional downregulation of the RB gene
Fang, X., Jin, X., Xu, H., Liu, L., Peng, H.-Q., Hogg, D., Roth, J. A., Yu, Y., Xu, F., Bast, R. C., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201525 · Cited by 77
DNA methylation and cancer: ghosts and angels above the genes
Sinčić, N., & Herceg, Z. (2010) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3283412eb4 · Cited by 73
Bacolod, M. D., Schemmann, G. S., Giardina, S. F., Paty, P. B., Notterman, D. A., & Barany, F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3543 · Cited by 54
Ziegel, R., Shallop, A. J., Upadhyaya, P., Jones, R. A., & Tretyakova, N. Y. (2003) · Biochemistry · doi:10.1021/bi035259j · Cited by 38
Seed in soil, with an epigenetic view
Lin, H.-J. L., Zuo, T., Chao, J. R., Peng, Z., Asamoto, L., Yamashita, S. S., & Huang, T. H. ‐. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.12.004 · Cited by 33
Cited by
Mechanisms of Multidrug Resistance in Cancer Chemotherapy
Bukowski, K., Kciuk, M., & Kontek, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093233 · Cited by 1,757
Nagini, S. (2012) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v4.i7.156 · Cited by 509
Salinomycin as a Drug for Targeting Human Cancer Stem Cells
Naujokat, C., & Steinhart, R. (2012) · Journal of Biomedicine and Biotechnology · doi:10.1155/2012/950658 · Cited by 351
Protein Glycosylation and Tumor Microenvironment Alterations Driving Cancer Hallmarks
Peixoto, A., Relvas-Santos, M., Azevedo, R., Santos, L. L., & Ferreira, J. A. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00380 · Cited by 334
Liu, Q., Fang, L., Yu, G., Wang, D., Xiao, C.-L., & Wang, K. (2019) · Nature Communications · doi:10.1038/s41467-019-10168-2 · Cited by 324
Metadata
- Authors
- Kanwal, R., & Gupta, S.
- Venue
- Clinical Genetics
- Publisher
- Wiley
- Published
- 2011-12-08
- Volume
- 81
- Issue
- 4
- Pages
- 303-311
- ISSN
- 0009-9163 (ISSN-L)
- 1399-0004
- OpenAlex
- W2002032142
- Cited by
- 550
- References
- 70
- FWCI
- 7.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.